Franklin Resources
DCOY

Franklin Resources’s Decoy Therapeutics DCOY Stock Holding History

Franklin Resources’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1
Closed -$2.26M – 1532
2018
Q1 		$2.26M Hold
1
– – ﹤0.01% 1182
2017
Q4 		$1.58M Hold
1
– – ﹤0.01% 1254
2017
Q3 		$1.54M Hold
1
– – ﹤0.01% 1245
2017
Q2 		$1.74M Hold
1
– – ﹤0.01% 1251
2017
Q1 		$1.99M Hold
1
– – ﹤0.01% 1247
2016
Q4 		$2.39M Hold
1
– – ﹤0.01% 1201
2016
Q3 		$5.33M Buy
+1
New +$10.2M ﹤0.01% 1093
2016
Q2 		– Hold
0
– – – 1134
2016
Q1 		– Hold
0
– – – 1144
2015
Q4 		– Hold
0
– – – 1158
2015
Q3 		– Hold
0
– – – 1173
2015
Q2 		– Hold
0
– – – 1173
2015
Q1 		– Hold
0
– – – 1155

Other funds holding DCOY

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Franklin Resources's DCOY Position: Q2 2018 in Review

Franklin Resources sold out of Decoy Therapeutics (DCOY) in Q2 2018, closing a stake of 1 share — an estimated $2.26M sold.

Franklin Resources first reported a position in DCOY in Q3 2016 and held it in 7 quarters. The position peaked at $5.33M in Q3 2016. 1 fund tracked by Wall St. Rank holds DCOY as of Q2 2018.

  • Franklin Resources reported no remaining Decoy Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Franklin Resources sold 1 Decoy Therapeutics share in Q2 2018, an estimated $2.26M.
  • Franklin Resources first reported a position in Decoy Therapeutics in Q3 2016 and held it in 7 quarters.
  • Franklin Resources's Decoy Therapeutics position peaked at $5.33M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Decoy Therapeutics as of Q2 2018.

Based on Franklin Resources's 13F filing for Q2 2018, filed 14 Aug 2018.